FDA Approved Medication to Reduce Binge Eating and/or Purging

NCT02553824 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Binge Eating Disorder
Bulimia Nervosa

Interventions

DRUG: Phentermine/Topiramate-First
DRUG: Placebo

Sponsor

Stanford University